China Isotope & Radiation Corporation

SEHK:1763 Rapport sur les actions

Capitalisation boursière : HK$3.4b

China Isotope & Radiation Résultats passés

Passé contrôle des critères 1/6

China Isotope & Radiation a connu une croissance annuelle moyenne de ses bénéfices de 7.9%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en hausse à 14.7% par an. Les revenus ont augmenté de en hausse à un taux moyen de 13.6% par an. Le rendement des capitaux propres de China Isotope & Radiation est 10.9% et ses marges nettes sont de 6%.

Informations clés

7.9%

Taux de croissance des bénéfices

7.9%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie13.7%
Taux de croissance des recettes13.6%
Rendement des fonds propres10.9%
Marge nette6.0%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

May 05
China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

Recent updates

China Isotope & Radiation Corporation's (HKG:1763) 36% Share Price Surge Not Quite Adding Up

Oct 07
China Isotope & Radiation Corporation's (HKG:1763) 36% Share Price Surge Not Quite Adding Up

China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

May 05
China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

Apr 26
Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet

Mar 28
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet

There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

May 13
There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Feb 07
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends

Dec 20
China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends

A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)

Oct 28
A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)

China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Sep 30
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Aug 30
There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?

Jun 10
Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt

Apr 11
China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt

Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?

Dec 28
Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Oct 26
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal

Oct 08
Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal

Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?

Sep 05
Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?

Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture

Jun 13
Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture

When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?

May 24
When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet

Apr 01
China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet

Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)

Mar 14
Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)

The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More

Feb 04
The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More

Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Jan 09
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Ventilation des recettes et des dépenses

Comment China Isotope & Radiation gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SEHK:1763 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 246,7064002,405282
31 Mar 246,6703862,441294
31 Dec 236,6353712,477306
30 Sep 236,4543882,393313
30 Jun 236,2734062,308319
31 Mar 236,2143992,352310
31 Dec 226,1543922,396301
30 Sep 225,9293672,430267
30 Jun 225,7053412,463233
31 Mar 225,4253382,397214
31 Dec 215,1443362,331196
30 Sep 214,9792922,289192
30 Jun 214,8152482,247188
31 Mar 214,5442312,083170
31 Dec 204,2742141,918153
30 Sep 204,0632331,94399
30 Jun 203,8512531,96745
31 Mar 203,9202912,07322
31 Dec 193,9893292,1790
30 Sep 193,7603412,0360
30 Jun 193,5313521,8940
31 Mar 193,3903371,8040
31 Dec 183,2503221,7150
30 Sep 183,0853081,6170
30 Jun 182,9202941,5190
31 Mar 182,7962831,4560
31 Dec 172,6722711,3920
31 Dec 162,3632621,1920
31 Dec 152,1522541,0450

Des revenus de qualité: 1763 a un niveau élevé de bénéfices non monétaires.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 1763 sont inférieures à celles de l'année dernière 1763. (6%) sont inférieures à celles de l'année dernière (6.5%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de 1763 ont augmenté de 7.9% par an au cours des 5 dernières années.

Accélération de la croissance: 1763 a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.

Bénéfices par rapport au secteur d'activité: 1763 a enregistré une croissance négative de ses bénéfices ( -1.4% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Medical Equipment ( -4.3% ).


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de 1763 ( 10.9% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé